Search
for
Sort by
Research 781–810 of 1000+
- Nanocarrier Systems for Transdermal Drug Delivery
- Clinical picture of infectious syphilis
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Microneedling in Dermatology: A Review
- A practical approach to feline symmetrical alopecia
- Microneedles as a perspective for transdermal therapeutic systems
- Cult of the Body Beautiful: At What Cost?
- Haut und Haar
- Seasonal Variations in Public Interest in Dermatological Conditions in Türkiye: Google Trends Analysis
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- DERMATOLOGICAL CONDITIONS IN TRANSGENDER PATIENTS: A SYSTEMATIC REVIEW
- Dermatologia e Procedimentos Estéticos Ed. XXVII
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Hair follicle stem cells promote epidermal regeneration under expanded condition
- Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
- A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
- Alopecia por diluição da cor em uma cadela Staffordshire Bull Terrier azul: Relato de caso
- Dermal niche signaling and epidermal stem cells
- Uso actual de la vitamina D en dermatología
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Dermatological history and examination
- 皮膚組織の再生に向けた皮膚由来幹細胞に関する研究
- Surgical Anatomy of the Scalp
- Eficacia del aceite esencial de Neem sobre la piel y pelaje de gatos con dermatofitosis
- Techniques d'épargne cutanée dans la chirurgie de la gynécomastie
- Effects of Periplaneta americana extracts on the growth and proliferation of cutaneous interstitial cells in cutaneous-wound healing
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Tumor suppressor identity can contribute to heterogeneity of phenotype in hair follicle stem cell‐induced squamous cell carcinoma
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program